Skip to main content

Advertisement

SpringerLink
Log in

Standardized Uptake Values in the Primary Lesions of Non-Small-Cell Lung Cancer in FDG-PET/CT Can Predict Regional Lymph Node Metastases

  • Thoracic Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Purpose

Maximum standardized uptake values (SUVmax) at the primary lesions of non-small-cell lung cancer in 18F-fluorodeoxyglucose positron emission tomography combined with computed tomography (FDG-PET/CT), and the microscopic local extension of tumors were examined to develop reliable criteria to determine candidates for sublobar resection.

Methods

We retrospectively analyzed 209 patients who underwent lobectomy, bilobectomy, or pneumonectomy with systematic lymph node dissection. Preoperative SUVmax at the primary lesion, microscopic lymphatic, venous, and pleural invasion in addition to lymph node metastases in the resected specimens were examined. Receiver operating characteristic analyses were used to predict an optimal cutoff for lymph node metastases.

Results

With receiver operating characteristic analysis, the areas under the curve for SUVmax and tumor size were 0.693 and 0.545, respectively, suggesting SUVmax superiority for prediction of lymph node metastases with a cutoff of 2.9. When a tumor was ≤2.0 cm (n = 41, 19.6 %), the percentages of microscopic lymphatic invasion, venous invasion, pleural invasion, and lymph node metastases were 12.2, 7.3, 4.9, and 17.1 %, respectively. When SUVmax was <3.0 (n = 91, 43.5 %), these percentages were 15.4, 3.3, 7.7, and 8.8 %, showing that SUVmax could efficiently exclude nodal metastases in more cases than tumor size. The postoperative 5-year survival rate was 86.6 % in patients with SUVmax < 3.0 and 58.1 % in patients with SUVmax ≥ 3.0 (p < 0.001).

Conclusions

18F-FDG uptake value was more useful than tumor size for selecting patients with non-small-cell lung cancer suitable for intentional sublobar resection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non–small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg. 1995;60:615–22.

    Article  PubMed  CAS  Google Scholar 

  2. Nakamura H, Kawasaki N, Taguchi M, Kabasawa K. Survival following lobectomy vs limited resection for stage I lung cancer: a meta-analysis. Br J Cancer. 2005;92:1033–7.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  3. Asamura H, Nakayama H, Kondo H, Tsuchiya R, Shimosato Y, Naruke T. Lymph node involvement, recurrence, and prognosis in resected small, peripheral, non-small-cell lung carcinomas: are these carcinomas candidates for video-assisted lobectomy? J Thorac Cardiovasc Surg. 1996;111:1125–34.

    Article  PubMed  CAS  Google Scholar 

  4. Whitson BA, Groth SS, Andrade RS, Maddaus MA, Habermann EB, D’Cunha J. Survival after lobectomy versus segmentectomy for stage I non–small cell lung cancer: a population-based analysis. Ann Thorac Surg. 2011;92:1943–50.

    Article  PubMed  Google Scholar 

  5. Brown RS, Leung JY, Kison PV, Zasadny KR, Flint A, Wahl RL. Glucose transporters and FDG uptake in untreated primary human non–small cell lung cancer. J Nucl Med. 1999;40:556–65.

    PubMed  CAS  Google Scholar 

  6. de Geus-Oei LF, van Krieken JH, Aliredjo RP, et al. Biological correlates of FDG uptake in non–small cell lung cancer. Lung Cancer. 2007;55:79–87.

    Article  PubMed  Google Scholar 

  7. Vansteenkiste JF, Stroobants SG, Dupont PJ, et al. Prognostic importance of the standardized uptake value on (18)F-fluoro-2-deoxy-glucose-positron emission tomography scan in non-small-cell lung cancer: an analysis of 125 cases. Leuven Lung Cancer Group. J Clin Oncol. 1999;17:3201–6.

    PubMed  CAS  Google Scholar 

  8. Higashi K, Ueda Y, Arisaka Y, et al. 18F-FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non–small cell lung cancer. J Nucl Med. 2002;43:39–45.

    PubMed  Google Scholar 

  9. Ohtsuka T, Nomori H, Watanabe K, et al. Prognostic significance of [(18)F]fluorodeoxyglucose uptake on positron emission tomography in patients with pathologic stage I lung adenocarcinoma. Cancer. 2006;107:2468–73.

    Article  PubMed  Google Scholar 

  10. Pillot G, Siegel BA, Govindan R. Prognostic value of fluorodeoxyglucose positron emission tomography in non–small cell lung cancer: a review. J Thorac Oncol. 2006;1:152–9.

    Article  PubMed  Google Scholar 

  11. Nakamura H, Hirata T, Kitamura H, Nishikawa J. Correlation of the standardized uptake value in FDG-PET with the expression level of cell-cycle-related molecular biomarkers in resected non–small cell lung cancers. Ann Thorac Cardiovasc Surg. 2009;15:304–10.

    PubMed  Google Scholar 

  12. Shiono S, Abiko M, Sato T. Positron emission tomography/computed tomography and lymphovascular invasion predict recurrence in stage I lung cancers. J Thorac Oncol. 2011;6:43–7.

    Article  PubMed  Google Scholar 

  13. Ueda K, Tanaka T, Hayashi M, Tanaka N, Li TS, Hamano K. What proportion of lung cancers can be operated by segmentectomy? A computed-tomography-based simulation. Eur J Cardiothorac Surg. 2012;41:341–5.

    Article  PubMed  Google Scholar 

  14. Veronesi G, Maisonneuve P, Pelosi G, et al. Screening-detected lung cancers: is systematic nodal dissection always essential? J Thorac Oncol. 2011;6:525–30.

    Article  PubMed  Google Scholar 

  15. Nakamura H, Saji H, Shinmyo T, et al. Close association of IASLC/ATS/ERS lung adenocarcinoma subtypes with glucose-uptake in positron emission tomography. Lung Cancer. 2015;87:28–33.

    Article  PubMed  Google Scholar 

  16. Goldstraw P. International Association for the Study of Lung Cancer. IASLC staging manual in thoracic oncology. Orange Park: Editorial Rx Press;2009.

    Google Scholar 

  17. Gupta NC, Tamim WJ, Graeber GG, Bishop HA, Hobbs GR. Mediastinal lymph node sampling following positron emission tomography with fluorodeoxyglucose imaging in lung cancer staging. Chest. 2001;120:521–7.

    Article  PubMed  CAS  Google Scholar 

  18. Guhlmann A, Storck M, Kotzerke J, Moog F, Sunder-Plassmann L, Reske SN. Lymph node staging in non–small cell lung cancer: evaluation by [18F]FDG positron emission tomography (PET). Thorax. 1997;52:438–41.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  19. Al-Sarraf N, Gately K, Lucey J, Wilson L, McGovern E, Young V. Mediastinal lymph node staging by means of positron emission tomography is less sensitive in elderly patients with non-small-cell lung cancer. Clin Lung Cancer. 2008;9:39–43.

    Article  PubMed  Google Scholar 

  20. Yoshikawa K, Tsubota N, Kodama K, Ayabe H, Taki T, Mori T. Prospective study of extended segmentectomy for small lung tumors: the final report. Ann Thorac Surg. 2002;73:1055–8.

    Article  PubMed  Google Scholar 

  21. Koike T, Yamato Y, Yoshiya K, Shimoyama T, Suzuki R. Intentional limited pulmonary resection for peripheral T1 N0 M0 small-sized lung cancer. J Thorac Cardiovasc Surg. 2003;125:924–8.

    Article  PubMed  Google Scholar 

  22. Swanson SJ. Segmentectomy for lung cancer. Semin Thorac Cardiovasc Surg. 2010;22:244–9.

    Article  PubMed  Google Scholar 

  23. Okada M, Yoshikawa K, Hatta T, Tsubota N. Is segmentectomy with lymph node assessment an alternative to lobectomy for non–small cell lung cancer of 2 cm or smaller? Ann Thorac Surg. 2001;71:956–60.

    Article  PubMed  CAS  Google Scholar 

  24. Casiraghi M, Travaini LL, Maisonneuve P, et al. Lymph node involvement in T1 non-small-cell lung cancer: could glucose uptake and maximal diameter be predictive criteria? Eur J Cardiothorac Surg. 2011;39:e38–43.

    Article  PubMed  Google Scholar 

  25. Nakamura H, Saji H, Shinmyo T, et al. Association of IASLC/ATS/ERS histologic subtypes of lung adenocarcinoma with epidermal growth factor receptor mutations in 320 resected cases. Clin Lung Cancer. 2014.

  26. Nakamura K, Saji H, Nakajima R, et al. A phase III randomized trial of lobectomy versus limited resection for small-sized peripheral non–small cell lung cancer (JCOG0802/WJOG4607L). Jpn J Clin Oncol. 2010;40:271–4.

    Article  PubMed  Google Scholar 

  27. Meng X, Sun X, Mu D, et al. Noninvasive evaluation of microscopic tumor extensions using standardized uptake value and metabolic tumor volume in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2012;82:960–6.

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Department of Chest Surgery, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan

    Haruhiko Nakamura MD, PhD, Hisashi Saji MD, PhD, Hideki Marushima MD, PhD, Hiroyuki Kimura MD, Rie Tagaya MD, PhD & Noriaki Kurimoto MD, PhD

  2. Department of Pathology, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan

    Masahiro Hoshikawa MD, PhD & Masayuki Takagi MD, PhD

Authors
  1. Haruhiko Nakamura MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hisashi Saji MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hideki Marushima MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hiroyuki Kimura MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Rie Tagaya MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Noriaki Kurimoto MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Masahiro Hoshikawa MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Masayuki Takagi MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Haruhiko Nakamura MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nakamura, H., Saji, H., Marushima, H. et al. Standardized Uptake Values in the Primary Lesions of Non-Small-Cell Lung Cancer in FDG-PET/CT Can Predict Regional Lymph Node Metastases. Ann Surg Oncol 22 (Suppl 3), 1388–1393 (2015). https://doi.org/10.1245/s10434-015-4564-6

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-015-4564-6

Keywords

Search

Navigation